Testing effectiveness (Phase 2)UnknownNCT01755624
What this trial is testing
Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)
Who this might be right for
1-5 Brain Metastases From Non-Small Cell Lung Cancer
NovoCure Ltd. 18